These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27431864)

  • 21. Development of fluorometholone-loaded PLGA nanoparticles for treatment of inflammatory disorders of anterior and posterior segments of the eye.
    Gonzalez-Pizarro R; Silva-Abreu M; Calpena AC; Egea MA; Espina M; García ML
    Int J Pharm; 2018 Aug; 547(1-2):338-346. PubMed ID: 29800741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ocular pharmacokinetics of 0.5% pilocarpine with sodium hyaluronate in rabbits].
    Xu Y; Song JZ; Pang GR; Chen ZJ; Zhang JJ; Lü XF
    Zhonghua Yan Ke Za Zhi; 2004 Feb; 40(2):87-9. PubMed ID: 15059558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric dosing considerations in ophthalmology--dosage adjustments based on aqueous humor volume ratio.
    Patton TF
    J Pediatr Ophthalmol; 1977; 14(4):254-6. PubMed ID: 894449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
    Patel N; Nakrani H; Raval M; Sheth N
    Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-situ forming gels containing fluorometholone-loaded polymeric nanoparticles for ocular inflammatory conditions.
    Gonzalez-Pizarro R; Carvajal-Vidal P; Halbault Bellowa L; Calpena AC; Espina M; García ML
    Colloids Surf B Biointerfaces; 2019 Mar; 175():365-374. PubMed ID: 30554015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
    Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioequivalence Study Methods with Pharmacokinetic Endpoints for Topical Ophthalmic Corticosteroid Suspensions and Effects of Subject Demographics.
    Harigaya Y; Jiang X; Zhang H; Chandaroy P; Stier EM; Pan Y
    Pharm Res; 2018 Nov; 36(1):13. PubMed ID: 30443681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
    Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
    AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-cyclodextrins enhance bioavailability of pilocarpine.
    Freedman KA; Klein JW; Crosson CE
    Curr Eye Res; 1993 Jul; 12(7):641-7. PubMed ID: 8222723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle-delivery-system.
    Zimmer A; Mutschler E; Lambrecht G; Mayer D; Kreuter J
    Pharm Res; 1994 Oct; 11(10):1435-42. PubMed ID: 7855048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study.
    Rupenthal ID; Green CR; Alany RG
    Int J Pharm; 2011 Jun; 411(1-2):78-85. PubMed ID: 21453763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model.
    Desai SD; Blanchard J
    J Pharm Sci; 1998 Oct; 87(10):1190-5. PubMed ID: 9758675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits.
    Lee VH; Robinson JR
    J Pharm Sci; 1979 Jun; 68(6):673-84. PubMed ID: 458563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged, contemporaneous administration of pilocarpine and timolol increases the aqueous humor pilocarpine levels in rabbits.
    Burgalassi S; Chetoni P; Panichi L; Saettone MF
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):1-7. PubMed ID: 10048342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chitosan-coated ophthalmic submicro emulsion for pilocarpine nitrate].
    Wei J; He HL; Zheng CL; Zhu JB
    Yao Xue Xue Bao; 2011 Aug; 46(8):990-6. PubMed ID: 22007526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic prediction of the ocular absorption of an instilled drug with ophthalmic viscous vehicle.
    Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
    Biol Pharm Bull; 2000 Nov; 23(11):1352-6. PubMed ID: 11085365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary pharmacokinetic model of pilocarpine uptake and distribution in the eye.
    Himmelstein KJ; Guvenir I; Patton TF
    J Pharm Sci; 1978 May; 67(5):603-6. PubMed ID: 641790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologically based ocular pharmacokinetic modeling using computational methods.
    Missel PJ; Sarangapani R
    Drug Discov Today; 2019 Aug; 24(8):1551-1563. PubMed ID: 31319151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Determination of three formulations of pilocarpine in rabbit ocular aqueous by RP-HPLC].
    Wang XJ; Chen B; Yao TW; Zhang HC; Zeng S
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 33(1):33-6. PubMed ID: 14966937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vehicle effects on ocular drug bioavailability III: Shear-facilitated pilocarpine release from ointments.
    Sieg JW; Robinson JR
    J Pharm Sci; 1979 Jun; 68(6):724-8. PubMed ID: 458573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.